
Eli Lilly and Company
Founded Year
1876Stage
IPO | IPODate of IPO
1/1/1952Market Cap
811.66BStock Price
906.86Revenue
$0000About Eli Lilly and Company
Eli Lilly and Company operates as a pharmaceutical company. It is involved in developing medicines using biotechnology, chemistry, and genetic medicine to improve health outcomes. The company serves the healthcare sector with its pharmaceutical products. It was founded in 1876 and is based in Indianapolis, Indiana.
Loading...
ESPs containing Eli Lilly and Company
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The D2C prescription weight loss & metabolic services market offers weight loss and metabolic management services directly to consumers, typically without the need for traditional healthcare provider involvement. These services often utilize digital platforms, telemedicine, and personalized approaches to provide convenient, accessible, and evidence-based solutions for individuals seeking to manage…
Eli Lilly and Company named as Highflier among 15 other companies, including Amazon, Novo Nordisk, and Omada Health.
Loading...
Research containing Eli Lilly and Company
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Eli Lilly and Company in 8 CB Insights research briefs, most recently on Jul 3, 2025.

May 23, 2025
The AI in drug R&D market map
Expert Collections containing Eli Lilly and Company
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Eli Lilly and Company is included in 2 Expert Collections, including Fortune 500 Investor list.
Fortune 500 Investor list
590 items
This is a collection of investors named in the 2019 Fortune 500 list of companies. All CB Insights profiles for active investment arms of a Fortune 500 company are included.
HLTH 2025 Exhibitors
878 items
A look at the HLTH Vegas 2025 exhibitor list we’ve been building so your team can start scanning for relevant companies.
Eli Lilly and Company Patents
Eli Lilly and Company has filed 1028 patents.
The 3 most popular patent topics include:
- medical equipment
- diabetes
- drug delivery devices

Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
10/11/2023 | 4/8/2025 | Peptide hormones, Obesity, Potassium channel blockers, G protein coupled receptors, Diabetes | Grant |
Application Date | 10/11/2023 |
|---|---|
Grant Date | 4/8/2025 |
Title | |
Related Topics | Peptide hormones, Obesity, Potassium channel blockers, G protein coupled receptors, Diabetes |
Status | Grant |
Latest Eli Lilly and Company News
Nov 5, 2025
The Trump administration is negotiating a deal with weight-loss drugmakers Eli Lilly and Novo Nordisk that would allow the lowest doses of some of their obesity drugs to be sold to consumers at $149 for a month's supply via TrumpRx, according to people familiar with the matter. The deals would also result in Medicare and Medicaid covering the drugs for weight-loss, the people said, which would be a boon to the companies.
Eli Lilly and Company Frequently Asked Questions (FAQ)
When was Eli Lilly and Company founded?
Eli Lilly and Company was founded in 1876.
Where is Eli Lilly and Company's headquarters?
Eli Lilly and Company's headquarters is located at Lilly Corporate Center, Indianapolis.
What is Eli Lilly and Company's latest funding round?
Eli Lilly and Company's latest funding round is IPO.
Who are the investors of Eli Lilly and Company?
Investors of Eli Lilly and Company include Kleiner Perkins.
Who are Eli Lilly and Company's competitors?
Competitors of Eli Lilly and Company include Turning Point Therapeutics, GlaxoSmithKline - Antibiotics Business Cephalosporin, Viatris, Moderna, Novartis and 7 more.
Loading...
Compare Eli Lilly and Company to Competitors
Boehringer Ingelheim operates within the pharmaceutical and animal health sectors. The company conducts research and development of products for humans and animals. Boehringer Ingelheim serves the healthcare industry with an emphasis on pharmaceutical products. It was founded in 1885 and is based in Ingelheim am Rhein, Germany.

Novartis develops and offers a range of medicines aimed at treating serious diseases, providing support for patients and healthcare professionals, and conducting research to discover new therapies. The company also focuses on environmental sustainability and ethical practices in the pharmaceutical industry. It was founded in 1996 and is based in Basel, Switzerland.

Bristol-Myers Squibb operates as a biopharmaceutical company involved in the discovery, development, and delivery of medicines across various therapeutic areas. The company specializes in treatments for oncology, hematology, immunology, cardiovascular disease, and fibrosis, utilizing translational medicine and data analytics. Bristol-Myers Squibb also engages in health equity initiatives through its foundation to improve health outcomes for populations affected by serious diseases. It was founded in 1887 and is based in Princeton, New Jersey.

Daiichi Sankyo France operates as a global pharmaceutical company with a focus on providing therapeutic solutions in oncology and cardiology. The company offers treatments for various diseases including hypertension, dyslipidemia, diabetes, acute coronary syndrome, venous thromboembolism, breast cancer, metastatic melanoma, inflammatory diseases, and pain. Daiichi Sankyo France primarily serves the healthcare sector, providing innovative medications and supporting services to patients and medical professionals. It was founded in 2003 and is based in Rueil-Malmaison, France.

Angelini Industries focuses on health, industrial technology, and consumer goods. The company offers various products and services in these sectors and is involved in venture capital investments and research and development. Angelini Industries was formerly known as The Angelini Group. It was founded in 1919 and is based in Rome, Italy.

LifeArc operates as a self-financing medical research charity. The organization specializes in drug discovery, diagnostics development, antibody humanization, and intellectual property management, aiming to lab-based scientific discoveries into diagnostics, treatments, and cures. LifeArc collaborates with various sectors including the pharmaceutical industry, biotechnology sector, and academic institutions to develop and commercialize medical research. LifeArc was formerly known as MRC Technology. It was founded in 2000 and is based in London, United Kingdom.
Loading...





